Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
930studies shown
Showing 469-480 of 930
Drug study icon
CompletedNCT00074776

Acute Treatment of Bipolar II Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Stanford University
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugOver 18 Years
Countries
United States, Australia, India
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00276965

Bipolar II Depression: Lithium, SSRI, or the Combination

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT02582905

Clinical Medication Development for Bipolarity and Alcohol Use Disorders

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Addiction, ...BehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Sherwood Brown, MD, PhD
Condition
Bipolarity, Addiction, ...
Behavioral study icon
CompletedNCT00338806

Early Detection and Prevention of Mood Disorders in Children of Parents With Bipolarity

This study exists to explore whether psychoeducation, a guided learning and support program, could improve care and understanding. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better support energy, concentration, and everyday functioning.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBehavioralFrom 12 Years to 17 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity, Depression
Device study icon
Active Not RecruitingNCT03788811

ERG Components in Schizophrenia and Bipolarity type I

This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 50 Years
Countries
United States, Australia, Canada
Sponsor
diaMentis Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This study exists to explore whether the medication Patients could improve care and understanding. Researchers are trying to understand what the medication Patients could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czechia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czechia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01284517

Lurasidone HCI - A 6-week Phase 3 Study of people with Bipolar I Depression

This study is completed in the United States, in Canada, in Colombia, .... It focuses on depression.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT02090595

Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolarity

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, AnxietyBehavioralFrom 10 Years to 17 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity, Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.